Commissioning of optically stimulated luminescence dosimeters for use in radiotherapy
- 1. Australian Radiation Protection and Nuclear Safety Agency, 619 Lower Plenty Road, Yallambie, VIC 3085 (Australia)
- 2. Physical Sciences, Peter MacCallum Cancer Centre, 7 St Andrews Place, East Melbourne, VIC 3002 (Australia)
Description
The Australian Clinical Dosimetry Service (ACDS) is a government initiative to provide all radiation therapy centers in Australia with access to free and independent dosimetric audit services. Based out of the Australian Radiation Protection and Nuclear Safety Agency, the ACDS commenced audit operations in 2010. Aim: The objective of this work was to commission Optically Stimulated Luminescence Dosimeters (OSLDs) as a replacement for Thermoluminescence Dosimeters (TLD) for use in the ACDS's remote auditing program, with a view to extending their application to higher level dosimetry in anthropomorphic phantoms. Materials and Method: The In-Light nanoDots™ OSLD system from Landauer Inc. was commissioned using both the Australian National Linear Accelerator, an Elekta Synergy II, and an Eldorado Co-60 unit. The linearity, signal depletion, fading, energy dependence, reproducibility and resetting of nanoDot™ dosimeters were determined for clinical photon and electron beams. Results: NanoDots™ OSLDs demonstrate; supralinearity dependent on the overall accumulated dose. Little signal depletion per readout (0.03% per read). Reproducible fading, characterised by an initial transient signal decay over a period of 16 min post irradiation, followed by a predictable logarithmic decay resulting in signal decrease of 3% over several months. Little dependence on energy or modality over the clinical range. Optical resetting tests show negligible change in sensitivity post reset for up to five cycles. Conclusion: Modern OSLDs such as the nanoDots™ dosimeters provide a viable alternative to the established TLD technology with comparable accuracy and greater efficiency. The efficiency, reusability and accuracy of nanoDot™ dosimeters makes them an ideal candidate for the large-scale dosimetry operations currently undertaken by the ACDS. - Highlights: ► We detail the commissioning process for use of OSLD in radiotherapy. ► OSLD shows promise as a replacement for TLD. ► OSLD provides an efficient tool in large scale dosimetry operations. ► The physical properties of OSLD are detailed and reported
Availability note (English)
Available from http://dx.doi.org/10.1016/j.radmeas.2013.01.012Additional details
Identifiers
- DOI
- 10.1016/j.radmeas.2013.01.012;
- PII
- S1350-4487(13)00025-5;
Publishing Information
- Journal Title
- Radiation Measurements
- Journal Volume
- 51-52
- Journal Page Range
- p. 31-39
- ISSN
- 1350-4487
- CODEN
- RMEAEP
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 46120068
- Subject category
- S61: RADIATION PROTECTION AND DOSIMETRY;
- Descriptors DEI
- ACCURACY; ARPANSA; AUDITS; COBALT 60; COMMISSIONING; COMPARATIVE EVALUATIONS; ELECTRON BEAMS; ENERGY DEPENDENCE; LINEAR ACCELERATORS; LUMINESCENCE; RADIATION DOSES; RADIOTHERAPY; READOUT SYSTEMS; THERMOLUMINESCENT DOSEMETERS; THERMOLUMINESCENT DOSIMETRY
- Descriptors DEC
- ACCELERATORS; AUSTRALIAN ORGANIZATIONS; BEAMS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; COBALT ISOTOPES; DOSEMETERS; DOSES; DOSIMETRY; EMISSION; EVALUATION; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LEPTON BEAMS; LUMINESCENT DOSEMETERS; MEASURING INSTRUMENTS; MEDICINE; MINUTES LIVING RADIOISOTOPES; NATIONAL ORGANIZATIONS; NUCLEAR MEDICINE; NUCLEI; ODD-ODD NUCLEI; PARTICLE BEAMS; PHOTON EMISSION; RADIOISOTOPES; RADIOLOGY; THERAPY; YEARS LIVING RADIOISOTOPES
Optional Information
- Copyright
- Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.